Mucosal Improvement in Patients With Moderate to Severe Postoperative Endoscopic Recurrence of Crohn’s Disease and Azathioprine Metabolite Levels

Simultaneous Quantification of Eleven Thiopurine Nucleotides by Liquid Chromatography-Tandem Mass Spectrometry

(2012) Ute Hofmann et al.   ANALYTICAL CHEMISTRY

Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy

(2010) P de Graaf et al.   BRITISH JOURNAL OF PHARMACOLOGY

Azathioprine versus mesalazine for prevention of postoperative clinical recurrence in patients with Crohn's disease with endoscopic recurrence: efficacy and safety results of a randomised, double-blind, double-dummy, multicentre trial

(2010) W. Reinisch et al.   GUT

Thiopurine maintenance therapy for ulcerative colitis

(2010) Hiroyuki Hanai et al.   INFLAMMATORY BOWEL DISEASES

Optimizing thiopurine therapy in inflammatory bowel disease

(2010) Jean-Baptiste Chevaux et al.   INFLAMMATORY BOWEL DISEASES

Crohnʼs disease activity index does not correlate with endoscopic recurrence one year after ileocolonic resection

(2010) Miguel Regueiro et al.   INFLAMMATORY BOWEL DISEASES

Pretreatment determination of TPMT – state of the art in clinical practice

(2009) A. Teml et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease

(2009) Filip Baert et al.   GASTROENTEROLOGY

Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohnʼs disease

(2009) Geert R. DʼHaens et al.   INFLAMMATORY BOWEL DISEASES

Factors predicting the outcome of disease activity assessment in Crohnʼs disease

(2009) Henrik Stjernman et al.   INFLAMMATORY BOWEL DISEASES

Endoscopy and MR enteroclysis: Equivalent tools in predicting clinical recurrence in patients with Crohnʼs disease after ileocolic resection

(2009) Stavroula Koilakou et al.   INFLAMMATORY BOWEL DISEASES

Meta-analysis of medical treatment and placebo treatment for preventing postoperative recurrence in Crohn’s disease (CD)

(2009) Yunfei Cao et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations

(2009) Gert Van Assche et al.   Journal of Crohns & Colitis

A 6-Thioguanine Nucleotide Threshold Level of 400 pmol/8 × 108Erythrocytes Predicts Azathioprine Refractoriness in Patients With Inflammatory Bowel Disease and Normal TPMT Activity

(2008) Xavier Roblin et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Highly Multiplexed Genotyping of Thiopurine S-Methyltransferase Variants Using MALDI-TOF Mass Spectrometry: Reliable Genotyping in Different Ethnic Groups

(2008) E. Schaeffeler et al.   CLINICAL CHEMISTRY

Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease

(2008) L.Y. Kwan et al.   DIGESTIVE AND LIVER DISEASE

Meta-Analysis of the Placebo Rates of Clinical Relapse and Severe Endoscopic Recurrence in Postoperative Crohn's Disease

(2008) Sara Renna et al.   GASTROENTEROLOGY

Azathioprine Is Superior to Budesonide in Achieving and Maintaining Mucosal Healing and Histologic Remission in Steroid-Dependent Crohnʼs Disease

(2008) Gerassimos J. Mantzaris et al.   INFLAMMATORY BOWEL DISEASES